123 results on '"Marzo Castillejo M"'
Search Results
2. Recomendaciones de prevención del cáncer
- Author
-
Marzo-Castillejo, M., Bellas-Beceiro, B., Vela-Vallespín, C., Nuin-Villanueva, M., Bartolomé-Moreno, C., Vilarrubí-Estrella, M., and Melús Palazón, E.
- Published
- 2012
- Full Text
- View/download PDF
3. Moving toward personalized breast cancer screening: The role of Primary Care
- Author
-
Universitat Rovira i Virgili, Pons-Rodriguez A; Marzo-Castillejo M; Cruz-Esteve I; Galindo-Ortego G; Hernández-Leal MJ; Rué M, Universitat Rovira i Virgili, and Pons-Rodriguez A; Marzo-Castillejo M; Cruz-Esteve I; Galindo-Ortego G; Hernández-Leal MJ; Rué M
- Abstract
Breast cancer is the leading cause of death in the world among women. The Spanish National Health System (SNHS) introduced population-based breast cancer screening in 2006. As in most European programs, risk is identified on the basis of age and a mammogram is offered every two years to women aged 50–69 years. Scientific evidence is moving toward personalized screening, based on individual risk. This article presents the clinical trials that will evaluate the efficacy of personalized screening and some studies carried out in our environment on the effect of informing women of the benefits and adverse effects of screening or the acceptability and feasibility of offering personalized screening, in the Shared Decision Making context. The Preventive Activities and Health Promotion Program can help transform screening in our SNHS.
- Published
- 2022
4. Moving toward personalized breast cancer screening: The role of Primary Care
- Author
-
Pons-Rodriguez A, Marzo-Castillejo M, Cruz-Esteve I, Galindo-Ortego G, Hernández-Leal MJ, Rué M, and Economia
- Abstract
El cáncer de mama es la primera causa de muerte en el mundo entre las mujeres. El Sistema Nacional de Salud (SNS) introdujo el cribado poblacional de cáncer de mama en 1990. Como en la mayoría de los programas europeos, el riesgo se identifica con base en la edad y se ofrece una mamografía cada dos años a mujeres de 50 a 69 años. La evidencia científica está avanzando hacia un cribado personalizado, basado en el riesgo individual. En este artículo se presentan los ensayos clínicos que evaluarán la eficacia del cribado personalizado y algunos estudios realizados en nuestro entorno sobre el efecto de informar a las mujeres de los beneficios y efectos adversos del cribado o la aceptabilidad y viabilidad de ofrecer cribado personalizado, que incluya la toma de decisiones compartidas. El Programa de Actividades Preventivas y Promoción de la Salud puede ayudar a transformar el cribado en nuestro SNS.
- Published
- 2022
- Full Text
- View/download PDF
5. 1737P Use of the predictive risk model LungFlagTM for lung cancer screening in screening in a Spanish reference center: A cost-effectiveness analysis
- Author
-
Olmedo Garcia, M.E., Gorospe, L., Seijo Maceiras, L.M., Pajares, V., Marzo Castillejo, M., Soriano, J.B., Trujillo, J.C., Arrabal, N., Flores, A., Garcia Verdes-Montenegro, F., Crespo, M., Carcedo, D., Heuser, C., Olghi, N., Choman, E.N., and Higuera Gomez, O.
- Published
- 2023
- Full Text
- View/download PDF
6. Clasificación de la calidad de la evidencia y fuerza de las recomendaciones: GRADE Working Group
- Author
-
Marzo-Castillejo, M. and Alonso-Coello, P.
- Published
- 2006
- Full Text
- View/download PDF
7. Estrategias de cribado en el cáncer colorrectal
- Author
-
Marzo Castillejo, M., Piñol, V., Mascort, J.J., and Piqué Badia, J.M.
- Published
- 2005
- Full Text
- View/download PDF
8. Prevención del cáncer de cérvix
- Author
-
Marzo-Castillejo, M., Cierco Peguero, P., and del Cura González, I.
- Published
- 2005
- Full Text
- View/download PDF
9. Guía de práctica clínica sobre menopausia y posmenopausia
- Author
-
Marzo-Castillejo, M. and Alonso-Coello, P.
- Published
- 2005
- Full Text
- View/download PDF
10. ¿Cuándo comenzar el cuidado del cáncer de mama?
- Author
-
Marzo-Castillejo, M., Alonso-Coello, P., and Nuin-Villanueva, M.A.
- Published
- 2004
- Full Text
- View/download PDF
11. Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update
- Author
-
Mangas-Sanjuan, C, Jover, R, Cubiella, J, Marzo-Castillejo, M, Balaguer, F, Bessa, X, Bujanda, L, Bustamante, M, Castelts, A, Diaz-Tasende, J, Diez-Redondo, P, Herraiz, M, Mascort-Roca, JJ, Pellise, M, Quintero, E, and Soc Espanola Epidemiologia
- Subjects
Clinical guidelines ,Interval cancer ,Endoscopic surveillance ,Colonoscopy ,Recommendations ,Colorectal cancer ,Colorectal cancer prevention - Abstract
There is limited scientific evidence available to stratify the risk of developing metachronous colorectal cancer after resection of colonic polyps and to determine surveillance intervals and is mostly based on observational studies. However, while awaiting further evidence, the criteria of endoscopic follow-up needs to be unified in our setting. Therefore, the Spanish Association of Gastroenterology, the Spanish Society of Family and Community Medicine, the Spanish Society of Digestive Endoscopy, and the Colorectal Cancer Screening Group of the Spanish Society of Epidemiology, have written this consensus document, which is included in chapter 10 of the "Clinical Practice Guideline for Diagnosis and Prevention of Colorectal Cancer. 2018 Update". Important developments will also be presented as regards the previous edition published in 2009. First of all, situations that require and do not require endoscopic surveillance are established, and the need of endoscopic surveillance of individuals who do not present a special risk of metachronous colon cancer is eliminated. Secondly, endoscopic surveillance recommendations are established in individuals with serrated polyps. Finally, unlike the previous edition, endoscopic surveillance recommendations are given in patients operated on for colorectal cancer. At the same time, it represents an advance on the European guideline for quality assurance in colorectal cancer screening, since it eliminates the division between intermediate risk group and high risk group, which means the elimination of a considerable proportion of colonoscopies of early surveillance. Finally, clear recommendations are given on the absence of need for follow-up in the low risk group, for which the European guidelines maintained some ambiguity. (C) 2018 Elsevier Espana, S.L.U. All rights reserved.
- Published
- 2019
12. Actualización en prevención y tratamiento del cáncer de próstata
- Author
-
Marzo Castillejo, M., Peña López, F., Alonso Coello, P., and Mascort Roca, J.J.
- Published
- 2002
- Full Text
- View/download PDF
13. Cribrado del cáncer de próstata
- Author
-
Marzo Castillejo, M., Cierco Peguera, P., and Bonfill Cosp, X.
- Published
- 2001
- Full Text
- View/download PDF
14. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update
- Author
-
Cubiella J, Marzo-Castillejo M, Jose Mascort-Roca J, Javier Amador-Romero F, Bellas-Beceiro B, Clofent-Vilaplana J, Carballal S, Ferrandiz-Santos J, Gimeno-Garcia A, Jover R, Mangas-Sanjuan C, Moreira L, Pellise M, Quintero E, Rodriguez-Camacho E, Vega-Villaamil P, Soc Espanola Med Familia & Comunit, and Asociacion Espanola Gastroenterolo
- Subjects
Population screening ,Lynch syndrome ,Prevention ,Diagnosis ,Clinical Practice Guideline ,Colonoscopy ,Polyposis ,Colorectal cancer ,digestive system diseases ,Faecal occult blood test ,Inflammatory bowel disease - Abstract
This document updates the recommendations made by the Spanish Society of Family and Community Medicine and the Spanish Association of Gastroenterology for the diagnosis and prevention of colorectal cancer (CRC). In order to evaluate the quality of the evidence and determine the recommendation levels of the interventions, we used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. This document establishes optimal delay intervals based on symptoms and the faecal immunochemical test (FIT) and recommends reducing the barriers for diagnostic confirmation in symptomatic subjects. With regard to CRC screening in the average-risk population, we propose strategies to achieve the universal implementation of organised CRC screening programmes based on biennial FIT and to increase the participation of the target population, including the involvement of Primary Healthcare. This Clinical Practice Guideline recommends universal screening for Lynch syndrome with mismatch repair proteins immunohistochemistry or microsatellite instability in incident CRCs and the use of gene panels in patients with adenomatous polyposis. It also updates the strategies to reduce the incidence and mortality of both CRC and other tumours associated with hereditary syndromes. Regarding non-hereditary familial CRC and surveillance after resection of adenomas, serrated lesions or CRC, we established the recommendations based on the attributable risk and the risk reduction of the proposed intervention. Finally, the document includes recommendations regarding surveillance intervals in inflammatory bowel disease and the attitude towards dysplasia. (C) 2018 Elsevier Espana, S.L.U. All rights reserved.
- Published
- 2018
15. Clinical practice guidelines for the management of constipation in adults. Part 1: Definition, aetiology and clinical manifestations
- Author
-
Serra, J, Mascort-Roca, J, Marzo-Castillejo, M, Aros, SD, Santos, JF, Rubio, ERD, and Manrique, FM
- Subjects
Clinical practice guidelines ,Constipation ,Chronic disease - Abstract
Clinical practice guidelines for the management of constipation in adults aim to generate recommendations on the optimal approach to chronic constipation in the primary care and specialized outpatient setting. Their main objective is to provide healthcare professionals who care for patients with chronic constipation with a tool that allows them to make the best decisions about the prevention, diagnosis and treatment of this condition. They are intended for family physicians, primary care and specialist nurses, gastroenterologists and other health professionals involved in the treatment of these patients, as well as patients themselves. The guidelines have been developed in response to the high prevalence of chronic constipation, its impact on patient quality of life and recent advances in pharmacological management. The Grading of Recommendations Assessment, Development and Evaluation Working Group (GRADE) system has been used to classify the scientific evidence and strengthen the recommendations. (C) 2016 Elsevier Espana, S.L.U., AEEH y AEG. All rights reserved.
- Published
- 2017
16. GRADE: Methodology for formulating and grading recommendations in clinical practice
- Author
-
Sanabria, AJ, Rigau, D, Rotaeche, R, Selva, A, Marzo-Castillejo, M, and Alonso-Coello, P
- Subjects
Evidence-based medicine ,Guideline adherence ,Practice guidelines - Abstract
Clinical practice guidelines (CPG) provide recommendations on the benefits and harms of different healthcare interventions. Proper CPG development and implementation can potentially reduce variability in clinical practice while improving its quality and safety. The GRADE system is used to assess the quality of evidence and to grade the strength of recommendations in the context of the development of CPGs, systematic reviews or health technology assessments. The aim of this article is to describe the main characteristics of the GRADE system through relevant examples in the context of primary care. (C) 2013 Elsevier Espana, S.L.U. All rights reserved.
- Published
- 2015
17. Índice de autores
- Author
-
Aguayo Ortiz, Rafael, Alberny Iglesias, Mireia, Albó Poquí, Anna, Aldaz Herce, Pablo, Arando Lasagabaster, Maider, Arribas García, Rosa Ana, Arribas Mir, Lorenzo, Bailón Muñoz, Emilia, Barragán Brun, Nieves, Benítez Camps, Mencia, Blanch Andreu, Jordi, Brau Tarrida, Albert, Brotons Cuixart, Carlos, Buitrago Ramírez, Francisco, Caballero Martínez, Fernando, Camarelles Guillem, Francisco, Campíñez Navarro, Manuel, Cano Pérez, Juan Francisco, Carrillo Fernández, Lourdes M.ª, Carrillo Muñoz, Ricardo, Casabona i Barbarà, Jordi, Casals Fransi, Jordi, Casals Peidró, Elias, Casanova Seuma, Josep Manel, Casanovas Font, Jordi, Casas Aranda, Isabel, Castejón Castejón, Jordi, Cegri Lombardo, Francisco, Ciurana Misol, Ramón, Claramunt Mendoza, Jaume, Coll Jordà, Rosa, Company Escales, Àngels, Contel Segura, Joan Carles, Córdoba García, Rodrigo, von Wichmann, Mariano de la Figuera, de la Flor i Brú, Josep, Díaz Rodríguez, Paula, Fàbrega Górriz, Oriol, Falgás Franco, Josep, del Carmen Fernández Alonso, M.ª, del Rosario Fernández García, M.ª, Ferrer Angelini, Carlos, Forcada Gisbert, Jordi, García García, Eva, García-Giralda Ruiz, Luis, Garrell Lluís, Imma, Gimbert Ràfols, Rosa M.ª, Gimferrer Artigas, Núria, Gómez Marco, José Javier, Gómez Martín, Óscar, González Compta, Xavier, González Touya, Marta, Gutiérrez Jiménez, Núria, Herrero Velázquez, Sonia, Juncadella García, Enrique, Landa Goñi, Jacinta, Ledesma Castelltort, Albert, Limón Ramírez, Esther, Antònia Llauger Rosselló, M.ª, Llor Vilà, Carles, López Grau, Mercè, Marès Bermúdez, Josep, Martín Cantera, Carlos, Ángeles Martín Laso, M.ª, Mercè Marzo Castillejo, M., Mascort Roca, Juanjo, Moragas Moreno, Ana, Luisa Morató Agustí, M.ª, Moreno Ripoll, Francesc, Negredo Bravo, Luis Javier, Ortega del Moral, Amparo, Sánchez-Pinilla, Ricardo Ortega, Caballero Francisco, Luis Pérez, Plana Blanco, Antoni, Ramos Blanes, Rafel, Retana Puigmartí, Mercedes, Ribera Pibernat, Miquel, Ridao Redondo, Marisa, Rodríguez Alonso, Juan José, Rodríguez Mur, Paloma, de Adana Pérez, Ricardo Ruiz, Salvá Siquier, Antonio, Sánchez Montoya, Jesús, Santaeugenia González, Sebastián J., Santos Pedro, Tomás, Serra Majem, Lluís, Simonet Aineto, Pere Josep, Solanas Saura, Pascual, Val Jiménez, Alicia, Vázquez Villegas, José, Vilardell Tarrés, Miquel, Villena Collado, Herminia, Vinyoles i Bargalló, Ernest, and Asunción Wilke Trinxant, M.ª
- Published
- 2019
- Full Text
- View/download PDF
18. Manejo del paciente con dispepsia. Guía de práctica clínica. Actualización 2012. Resumen ejecutivo
- Author
-
Gisbert J.P., Calvet Calvo X., Ferrándiz Santos J., Mascort Roca J.J., Alonso-Coello P., and Marzo Castillejo M.
- Subjects
practice guideline ,article ,Humans ,dyspepsia ,human ,Algorithms - Abstract
The "Preparation of Clinical Practice Guidelines in Digestive Diseases, from Primary Care to Specialist Care" Program, is a joint project by the Spanish Gastroenterology Association (AEG), the Spanish Society of Family and Community Medicine (SEMFyC), and the IberoAmerican Cochrane Center (CCI). We present the update of the Guidelines on the Management of Dyspepsia, which was published in 2003. The essential criteria provided in the AGREE (Appraisal of Guidelines, Research and Evaluation for Europe) Instrument were taken into account in the preparation of this document. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) system was used to classify the scientific evidence and strengthen the recommendations. © 2011 Elsevier Espana, S.L. All rights reserved.
- Published
- 2012
- Full Text
- View/download PDF
19. Appropriateness of colonoscopy requests according to EPAGE-II in the Spanish region of Catalonia
- Author
-
Marzo-Castillejo, M., primary, Almeda, J., additional, Mascort, JJ, additional, Cunillera, O., additional, Saladich, R., additional, Nieto, R., additional, Piñeiro, P., additional, Llagostera, M., additional, Cantero, FX., additional, Segarra, M., additional, and Puente, D., additional
- Published
- 2015
- Full Text
- View/download PDF
20. Strategies for increasing the participation of women in community breast cancer screening
- Author
-
Bonfill Cosp X., Marzo Castillejo M., Pladevall Vila M., Marti J., and Emparanza J.I.
- Subjects
mass screening ,breast tumor ,Patient Selection ,review ,clinical trial ,methodology ,Breast Neoplasms ,community care ,female ,health care quality ,Humans ,Clinical Trials ,human ,Community Health Services ,Patient Participation ,Program Evaluation - Abstract
Background: Strategies for reducing breast cancer mortality in western countries have focused on screening, at least for women aged 50 to 69 years. One of the requirements of any community screening program is to achieve a high participation rate, which is related to methods of invitation. Therefore, it was decided to systematically review the scientific evidence on the different strategies aimed at improving women's participation in breast cancer screening programs and activities. Objectives: To assess the effectiveness of different strategies for increasing the participation rate of women invited to community (population-based) breast cancer screening activities or mammography programs. Search methods: MEDLINE (1966-2000), CENTRAL (2000), and EMBASE (1998-1999) searches for 1966 to 1999 were supplemented by reports and letters to the European Screening Breast Cancer Programs (Euref Network). Selection criteria: Both published and unpublished trials were eligible for inclusion, provided the women had been invited to a community breast screening activity or program and had been randomised to an intervention group or a control group with no active intervention. Data collection and analysis: We identified 151 articles, which were reviewed independently by two people. The discrepancies were resolved by a third reviewer in order to reach consensus. Thirty-four studies were excluded because they lacked a control group; 58 of the other 117 articles were considered as opportunistic and not community-based; 59 articles, which reported 70 community-based randomised controlled trials or clinical controlled trials, were accepted. In 24 of these, the control group had not been exposed to any active intervention, but 8 of the 24 had to be excluded because the denominator for estimating attendance was unknown. At the end, 16 studies constituted the material for this review, although two studies were further excluded because their groups were not comparable at baseline. Data from all but one study were based on or converted to an intention-to-treat analysis. Attendance in response to the mammogram invitation was the main outcome measure. Main results: The evidence favoured five active strategies for inviting women into community breast cancer screening services: letter of invitation (OR 1.66, 95% CI 1.43 to 1.92), mailed educational material (Odds Ratio(OR) 2.81, 95% Confidence Interval (CI) 1.96 to 4.02), letter of invitation plus phone call (OR 2.53, 95% CI 2.02 to 3.18), phone call (OR 1.94, 95% CI 1.70 to 2.23), and training activities plus direct reminders for the women (OR 2.46, 95% CI 1.72 to 3.50). Home visits did not prove to be effective (OR 1.06, 95 % CI 0.80 to 1.40) and letters of invitation to multiple examinations plus educational material favoured the control group (OR 0.62, 95 % CI 0.32 to 1.20). Authors' conclusions: Most active recruitment strategies for breast cancer screening programs examined in this review were more effective than no intervention. Combinations of effective interventions can have an important effect. Some costly strategies, as a home visit and a letter of invitation to multiple screening examinations plus educational material, were not effective. Further reviews comparing the effective interventions and studies that include cost-effectiveness, women's satisfaction and equity issues are needed. Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
- Published
- 2001
21. Índice de autores
- Author
-
Aguayo Ortiz, Rafael, Agudo Trigueros, Antonio, Alberny Iglesias, Mireia, Albó Poquí, Anna, Aldaz Herce, Pablo, Altisent Trota, Rogelio, Amado Guirado, Ester, Arando Lasagabaster, Maider, Argimón Pallàs, Josep M.ª, Arribas García, Rosa Ana, Arribas Mir, Lorenzo, Bailón Muñoz, Emilia, Barberà Viala, Júlia, Barragán Brun, Nieves, Benítez Camps, Mencia, Blanch Andreu, Jordi, Borrell i Carrió, Francisco, Borrell Thió, Carme, Bosch Fontcuberta, Josep M.ª, Brau Tarrida, Albert, Brotons Cuixart, Carlos, Miguel Bueno Ortiz, José, Buitrago Ramírez, Francisco, Caballero Martínez, Fernando, Calderón Gómez, Carlos, Camarelles Guillem, Francisco, Francisco Cano Pérez, Juan, Carrillo Fernández, Lourdes M.ª, Carrillo Muñoz, Ricardo, Casabona i Barbarà, Jordi, Casals Fransi, Jordi, Casals Peidró, Elias, Casanova Seuma, Josep Manel, Casanovas Font, Jordi, Casas Aranda, Isabel, Castejón Castejón, Jordi, Cegri Lombardo, Francisco, Ceitlin, Julio, Concepción Celaya Lecea, M.ª, Ciurana Misol, Ramon, Claramunt Mendoza, Jaume, Coll Jordà, Rosa, Company Escales, Àngels, Carles Contel Segura, Joan, Córdoba García, Rodrigo, Davins Miralles, Josep, de la Figuera von Wichmann, Mariano, de la Flor i Brú, Josep, de la Revilla Ahumada, Luis, de los Ríos Álvarez, Ana M.ª, Díaz Rodríguez, Paula, Belén Enfedaque Montes, M.ª, Fàbrega Górriz, Oriol, Falgás Franco, Josep, del Carmen Fernández Alonso, M.ª, del Rosario Fernández García, M.ª, Ferrer Angelini, Carlos, Forcada Gisbert, Jordi, Foz Gil, Gonçal, García García, Eva, García-Giralda Ruiz, Luis, Garrell Lluís, Imma, Gené Badia, Joan, Gens Barberà, Montserrat, Gérvas Camacho, Juan, Gimbert Ràfols, Rosa M.ª, Gimferrer Artigas, Núria, Gofin, Jaime, Gómez Gascón, Tomás, Javier Gómez Marco, José, Gómez Martín, Óscar, González Compta, Xavier, González Svatetz, Carlos A., González Touya, Marta, Guarga Rojas, Alex, Gutiérrez Jiménez, Núria, Herrero Velázquez, Sonia, Iglesias Rodal, Manuel, Jiménez Villa, Josep, Juncadella García, Enrique, Landa Goñi, Jacinta, Ledesma Castelltort, Albert, Limón Ramírez, Esther, Llauger Rosselló, M. Antònia, Llor Vilà, Carles, López Grau, Mercè, López Fernández, Luis Andrés, Madridejos Mora, Rosa, Marès Bermúdez, Josep, Martín Cantera, Carlos, Martín Espíldora, M.ª Nieves, Martín Laso, M.ª Ángeles, Martín Zurro, Amando, Marzo Castillejo, M. Mercè, Mascort Roca, Juanjo, Montaner Gomis, Isabel, Moragas Moreno, Ana, Luisa Morató Agustí, M.ª, Moreno Ripoll, Francesc, Muñoz Seco, Elena, Negredo Bravo, Luis Javier, Ortega del Moral, Amparo, Ortega Sánchez-Pinilla, Ricardo, Inez Padula Anderson, M.ª, Pareja Rosell, Clara, Pasarín Rua, M.ª Isabel, Perestelo Pérez, Lilisbeth, Plana Blanco, Antoni, Ramos Blanes, Rafel, Retana Puigmartí, Mercedes, Ribera Pibernat, Miquel, Ridao Redondo, Marisa, Roca Casas, Antònia, Rodríguez Alonso, Juan José, Rodríguez Barragán, M.ª, Rodríguez Mur, Paloma, Ruiz de Adana Pérez, Ricardo, Ruiz Riera, Rafael, Salvá Siquier, Antonio, Sánchez Montoya, Jesús, Santaeugenia González, Sebastián J., Santos Pedro, Tomás, Segura Benedicto, Andreu, Serra Majem, Lluís, Serrat Moré, Dolores, Simonet Aineto, Pere Josep, Solanas Saura, Pascual, Tejero Mas, Manuel, Val Jiménez, Alicia, Vázquez Villegas, José, Vilardell Tarrés, Miquel, Villena Collado, Herminia, Vinyoles i Bargalló, Ernest, and Wilke Trinxant, M.ª Asunción
- Published
- 2021
- Full Text
- View/download PDF
22. ¿Estamos convencidos de nuestro papel en la prevención y detección precoz del cáncer colorrectal?
- Author
-
Marzo-Castillejo, M., primary, Mascort Roca, J., additional, and Rodríguez-Moñino, A. Pastor, additional
- Published
- 2012
- Full Text
- View/download PDF
23. COPAGO: conclusiones desde la evidencia científica. Documento semFYC, octubre de 2010
- Author
-
Solanas Saura, Pascual, primary and Marzo Castillejo, M. Mercè, additional
- Published
- 2011
- Full Text
- View/download PDF
24. Las estatinas no afectan a la incidencia y la mortalidad por cáncer
- Author
-
Marzo Castillejo, M., primary
- Published
- 2006
- Full Text
- View/download PDF
25. Dosis bajas de aspirina (100 mg) no tienen efecto en la prevención del cáncer en la mujer
- Author
-
Marzo-Castillejo, M., primary
- Published
- 2005
- Full Text
- View/download PDF
26. Guía de práctica clínica sobre menopausia y posmenopausia: tratamiento de los síntomas vasomotores y vaginales (parte 1)
- Author
-
Alonso-Coello, P, primary, Marzo-Castillejo, M, additional, Ribes, M, additional, Delgado, A, additional, Coutado, A, additional, and Gutiérrez, B, additional
- Published
- 2005
- Full Text
- View/download PDF
27. Guía de práctica clínica sobre menopausia y posmenopausia: evaluación del riesgo de fractura y cribado de la osteoporosis (parte 2)
- Author
-
Alonso-Coello, P, primary, Marzo-Castillejo, M, additional, López García-Franco, A, additional, Isasi Zaragoza, C, additional, Landa Goñi, J, additional, and Nishishinya Aquino, B, additional
- Published
- 2005
- Full Text
- View/download PDF
28. Guía de práctica clínica de prevención del cáncer colorrectal: hacia un abordaje integral, integrado y coordinado
- Author
-
Bellas Beceiro, B., primary, Ferrándiz Santos, J., additional, Mascort Roca, J.J., additional, Amador Romero, F.J., additional, and Marzo Castillejo, M., additional
- Published
- 2004
- Full Text
- View/download PDF
29. Evidencias sobre la efectividad clínica de la utilización del PSA en la enfermedad prostática
- Author
-
Marzo Castillejo, M., primary and Bonfill Cosp, X., additional
- Published
- 2002
- Full Text
- View/download PDF
30. Dispepsia y redes neuronales
- Author
-
Alonso-Coello, P., primary and Marzo Castillejo, M., additional
- Published
- 2002
- Full Text
- View/download PDF
31. Cáncer gástrico: acortando las diferencias
- Author
-
Marzo Castillejo, M., primary
- Published
- 2001
- Full Text
- View/download PDF
32. Índice de autores
- Author
-
Alberny Iglesias, Mireia, Albó Poquí, Anna, Alcántara Bumbiedro, Serafina, Arribas García, Rosa Ana, Arribas Mir, Lorenzo, Avecilla Palau, Àngels, Bailón Muñoz, Emilia, Catarina Bargalló, Marina, Barrio Ruiz, Carmen, Batalla Martínez, Carme, Birulés i Pons, Martí, Bordas i Julve, José M.ª, Borrell i Carrió, Francesc, Borrell i Thió, Carme, Bras i Marquillas, Josep, Brotons Cuixart, Carlos, Buitrago Ramírez, Francisco, Caballero Martínez, Fernando, Calvo Hueros, Juan Ignacio, Cano Pérez, Juan Francisco, Carrera Santaliestra, María José, Carrillo Muñoz, Ricard, Casabona i Barbarà, Jordi, Casals Fransi, Jordi, Casals Peidró, Elias, Casanova Seuma, Josep Manel, Casanovas Font, Jordi, Castejón Castejón, Jordi, Cegri Lombardo, Francisco, Ciurana Misol, Ramón, Clapés Estapá, Jaume, Comín Bertrán, Eva, Company Escales, Àngels, Córdoba García, Rodrigo, Dalfó i Baqué, Antoni, Figuera von Wichmann, Mariano de la, Escarrabill Sanglas, Joan, Fàbrega Górriz, Oriol, Falgás Franco, Josep, Fernández Alonso, M.ª del Carmen, Ferrándiz Santos, Juan Alberto, Figuerola i Batista, Montserrat, Forcada Gisbert, Jordi, Franch Nadal, Josep, Garrell Lluis, Imma, Gimferrer Artigas, Nuria, Gómez Martín, Óscar, González Touya, Marta, Herrero Velázquez, Sonia, Juncadella García, Enrique, Landa Goñi, Jacinta, Lareo Copa, Susana, Ledesma Castelltort, Albert, Limón Ramírez, Esther, Llauger Rosselló, M.ª Antònia, Martín Cantera, Carlos, Marzo Castillejo, M. Mercè, Mascort i Roca, Juan José, Masvidal i Aliberch, Rosa M.ª, Matamoros Iraola, Jordi, Moreno Álvarez, Pedro J., Moreno Ripoll, Francesc, Naberan Toña, Karlos, Negredo Bravo, Luis Javier, Sánchez-Pinilla, Ricardo Ortega, Pallarés Robles, Jordi, Pasarín Rua, María Isabel, Pérez Grau, Marta, Plana Blanco, Antoni, Ramírez Hidalgo, Àngels, Ramos Blanes, Rafel, Ribera Pibernat, Miquel, Roca-Ribas Serdá, Francesc, Rodríguez Alonso, Juan José, de Adana Pérez, Ricardo Ruiz, Sáez Pomares, Manuel, Sanz Andrés, Concepción, Silveira de la Torre, Jesús María, Solanas Saura, Pascual, Tamayo Ojeda, Carmen, Tomás Santos, Pedro, Trias i Folch, Elisenda, Verjano Díaz, Francisco, Vilardell Tarrés, Miquel, Villena Collado, Herminia, and Wilke Trinxant, María Asunción
- Published
- 2014
- Full Text
- View/download PDF
33. Evaluation of the regular practice of breast cancer screening in a health area.
- Author
-
Bonfill Cosp, X, Marzo Castillejo, M, Sentís Crivillé, M, Rossell Mir, R, Gallardo Cistaré, X, Florensa Masip, R, Rivero Ferrer, E, and Moreno Quiroga, C
- Published
- 1996
- Full Text
- View/download PDF
34. Autores
- Author
-
Agudo Trigueros, Antonio, Alberny Iglesias, Mireia, Albó Poquí, Anna, Alcántara Bumbiedro, Serafina, Alonso Caballero, Jordi, Altisent Trota, Rogelio, Argimón i Pallàs, Josep M.ª, Arribas García, Rosa Ana, Arribas Mir, Lorenzo, Avecilla Palau, Àngels, Bailón Muñoz, Emilia, Catarina Bargalló, M.ª, Barrio Ruiz, Carmen, Batalla Martínez, Carme, Bellón Saameño, Juan Ángel, Birulés i Pons, Martí, Blay i Pueyo, Carles, Bordas i Julve, José M.ª, Borrell i Carrió, Francesc, Borrell i Thió, Carme, Bosch i Fontcuberta, Josep M.ª, Bras i Marquillas, Josep, Brotons Cuixart, Carlos, Buitrago Ramírez, Francisco, Caballero Martínez, Fernando, Calderón Gómez, Carlos, Calvo Hueros, Juan Ignacio, Cano Pérez, Juan Francisco, Carrera Santaliestra, M.ª José, Carrillo Muñoz, Ricard, Casabona i Barbarà, Jordi, Casajuana i Brunet, Josep, Casals Fransi, Jordi, Casals Peidró, Elias, Casanova Seuma, Josep Manel, Casanovas Font, Jordi, Castejón Castejón, Jordi, Catalán Ramos, Arancha, Cegri Lombardo, Francisco, Ceitlin, Julio, Ciurana Misol, Ramon, Clapés Estapá, Jaume, Comín Bertrán, Eva, Company Escales, Àngels, Contel i Segura, Joan Carles, Córdoba García, Rodrigo, Dalfó i Baqué, Antoni, Davins i Miralles, Josep, de la Figuera von Wichmann, Mariano, de la Revilla Ahumada, Luis, de los Ríos Álvarez, Ana M.ª, Escarrabill Sanglas, Joan, Fàbrega Górriz, Oriol, Falgás Franco, Josep, del Carmen Fernández Alonso, M.ª, Fernández de Sanmamed Santos, M.ª José, del Rosario Fernández García, M.ª, Ferrándiz Santos, Juan Alberto, Figuerola i Batista, Montserrat, Forcada Gisbert, Jordi, Foz Gil, Gonçal, Franch Nadal, Josep, Garrell Lluis, Imma, Gené Badia, Joan, Gens i Barberà, Montserrat, Gérvas Camacho, Juan, Gimferrer Artigas, Nuria, Gofin, Jaime, Gómez Gascón, Tomás, Gómez Martín, Óscar, González Svatetz, Carlos A., Grau Corral, Immaculada, Guarga Rojas, Àlex, Herrero Velázquez, Sonia, Iglesias Rodal, Manuel, Jiménez Villa, Josep, Jordán Martín, Matilde, Jovell Fernández, Albert J., Juncadella García, Enrique, Landa Goñi, Jacinta, Lareo Copa, Susana, Ledesma Castelltort, Albert, Limón Ramírez, Esther, Llauger Rosselló, M.ª Antònia, López Fernández, Luis Andrés, Marquet i Palomer, Roser, Martín Cantera, Carlos, Martín Espíldora, M.ª Nieves, Martín Laso, M.ª Ángeles, Martín Zurro, Amando, Martínez González, Olga, Marzo Castillejo, M. Mercè, Mascort i Roca, Juan José, Masvidal i Aliberch, Rosa M.ª, Matamoros Iraola, Jordi, Moreno Ripoll, Francesc, Naberan Toña, Karlos, Negredo Bravo, Luis Javier, Sánchez-Pinilla, Ricardo Ortega, Pallarés Robles, Jordi, Pasarín Rua, M.ª Isabel, Plana Blanco, Antoni, Ramírez Hidalgo, Àngels, Ramos Blanes, Rafel, Ribera Pibernat, Miquel, Roca-Ribas Serdá, Francesc, Rodríguez Alonso, Juan José, Ruiz de Adana Pérez, Ricardo, Ruiz-Giménez Aguilar, Juan Luis, Sáez Pomares, Manuel, Sanz Andrés, Concepción, Segura i Benedicto, Andreu, Serrat Moré, Dolores, Silveira de la Torre, Jesús M.ª, Solanas Saura, Pascual, Subías Loren, Pedro, Tomás Santos, Pedro, Trias i Folch, Elisenda, Valderas Martínez, José M.ª, Vázquez Villegas, José, Verjano Díaz, Francisco, Vilardell Tarrés, Miquel, Villena Collado, Herminia, and Wilke Trinxant, M.ª Asunción
- Published
- 2016
- Full Text
- View/download PDF
35. ¿Cómo clasificar la calidad de la evidencia y la fuerza de las recomendaciones?
- Author
-
Marzo-Castillejo, M., Alonso-Coello, P., and Rotaeche del Campo, R.
- Published
- 2006
- Full Text
- View/download PDF
36. Clinical practice guidelines on the management of rectorrhagia (updated 2007),Guía de práctica clínica sobre el manejo de la rectorragia (actualización 2007)
- Author
-
Alonso-Coello, P., Marzo-Castillejo, M., Mascort, J. J., Hervás, A. J., Viña, L. M., Ferrús, J. A., Ferrándiz, J., López-Rivas, L., Rigau, D., Ivan Solà, Bonfill, X., and Piqué, J. M.
37. Dispepsia y redes neuronales
- Author
-
Alonso-Coello, P. and Marzo Castillejo, M.
- Published
- 2003
- Full Text
- View/download PDF
38. 45 - Cáncer en la mujer
- Author
-
Marzo Castillejo, M. and Bailón Muñoz, E.
- Full Text
- View/download PDF
39. What factors empower general practitioners for early cancer diagnosis? A 20-country European Delphi Study
- Author
-
Tzanis, George, Harris, Michael, Brekke, Mette, Marzo-Castillejo, Mercè, Cifcili, Saliha Serap, Wawrzynek, Wojciech, Flamm, Maria, Buono, Nicola, Márkus, Bernadett, Zacay, Galia, Skuja, Ilze, Adzic, Zlata Ozvacic, Iacob, Mihai, Asenova, Radost, Petek, Davorina, Buczkowski, Krzysztof, Curtis, Pamela, Pilv-Toom, Liina, Hoffman, Robert, Smyrnakis, Emmanouil, and Tzanis G., Harris M., Brekke M., Marzo-Castillejo M., ÇİFÇİLİ S. S. , Wawrzynek W., Flamm M., Buono N., Márkus B., Zacay G., et al.
- Subjects
Social Sciences and Humanities ,Delphi Technique ,Social Sciences (SOC) ,Family Medicine ,SOCIAL SCIENCES, GENERAL ,SAĞLIK BAKIM BİLİMLERİ VE HİZMETLERİ ,Delphi method ,610 Medicine & health ,Aile Hekimliği ,Sağlık Bilimleri ,Secondary Care ,Clinical Medicine (MED) ,Bakım Planlaması ,Sociology ,360 Social problems & social services ,Primary Health Care ,cancer ,empowerment ,general practitioners ,Neoplasms ,Health Sciences ,Humans ,Sosyal ve Beşeri Bilimler ,Klinik Tıp (MED) ,Sosyoloji ,Care Planning ,Early Detection of Cancer ,Halk, Çevre ve İş Sağlığı ,PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ,Internal Medicine Sciences ,Klinik Tıp ,360 Soziale Probleme, Sozialdienste ,Public Health, Environmental and Occupational Health ,Dahili Tıp Bilimleri ,Sosyal Bilimler Genel ,CLINICAL MEDICINE ,KAMU, ÇEVRE VE İŞ SAĞLIĞI ,HEALTH CARE SCIENCES & SERVICES ,Tıp ,Medicine ,Sosyal Bilimler (SOC) ,610 Medizin und Gesundheit - Abstract
Background: Some symptoms are recognised as red flags for cancer, causing the General Practitioner (GP) to refer the patient for investigation without delay. However, many early symptoms of cancer are vague and unspecific, and in these cases, a delay in referral risks a diagnosis of cancer that is too late. Empowering GPs in their management of patients that may have cancer is likely to lead to more timely cancer diagnoses. Aim: To identify the factors that affect European GPs’ empowerment in making an early diagnosis of cancer. Methods: This was a Delphi study involving GPs in 20 European countries. We presented GPs with 52 statements representing factors that could empower GPs to increase the number of early cancer diagnoses. Over three Delphi rounds, we asked GPs to indicate the clinical relevance of each statement on a Likert scale. The final list of statements indicated those that were considered by consensus to be the most relevant. Results: In total, 53 GPs from 20 European countries completed the Delphi process, out of the 68 GPs who completed round one. Twelve statements satisfied the pre-defined criteria for relevance. Five of the statements related to screening and four to the primary/secondary care interface. The other selected statements concerned information technology (IT) and GPs’ working conditions. Statements relating to training, skills and working efficiency were not considered priority areas. Conclusion: GPs consider that system factors relating to screening, the primary-secondary care interface, IT and their working conditions are key to enhancing their empowerment in patients that could have cancer. These findings provide the basis for seeking actions and policies that will support GPs in their efforts to achieve timely cancer diagnosis.
- Published
- 2022
- Full Text
- View/download PDF
40. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study
- Author
-
Irene Rivero, Guillem Pera, Andrea Burón, Antoni Castells, Mercedes Marzo-Castillejo, Mercedes Vilarrubí-Estrella, Pere Torán, Francesc Macià, Carmen Vela-Vallespín, Carolina Guiriguet, Jaume Grau, [Guiriguet C] Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Mataró, Spain. Departament de Medicina Familiar, Institut Català de la Salut, Barcelona, Spain. Centre d’Atenció Primària (CAP) Gòtic, Institut Català de la Salut, Barcelona, Spain. [Pera G, Castells A] Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Mataró, Spain. [Castells A] Servei de Gastroenterologia, Hospital Clínic, Universitat de Barcelona, Barcelona. Spain. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain. [Grau J] Servei de Medicina Preventiva, Departament de Salut Pública, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain. Departament d’Epidemiologia, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. [Rivero I] Departament de Medicina Familiar, Institut Català de la Salut, Barcelona, Spain. [Burón A, Macià F] Servei de Medicina Preventiva I Epidemiologia, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain. [Vela-Vallespín C, Vilarrubí-Estrella M] Departament de Medicina Familiar, Institut Català de la Salut, Santa Coloma de Gramenet, Spain. [Marzo-Castillejo M] Unitat de Suport a la Recerca Metropolitana Sud, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Cornellà de Llobregat, Spain, and IDIAP Jordi Gol
- Subjects
Male ,Cancer Research ,Cross-sectional study ,Colorectal cancer ,Còlon -- Càncer -- Prevenció ,Comorbidity ,0302 clinical medicine ,Còlon - Càncer ,030212 general & internal medicine ,Atenció primària -- Catalunya -- Barcelona ,Primary health care ,education.field_of_study ,Public health ,neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales [ENFERMEDADES] ,Incidence ,Middle Aged ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Càncer - Detecció precoç ,Oncology ,030220 oncology & carcinogenesis ,Population Surveillance ,Early detection of cancer ,Recte - Càncer ,Female ,Colorectal Neoplasms ,Neoplasias::Neoplasias por Localización::Neoplasias del Sistema Digestivo::Neoplasias Gastrointestinales::Neoplasias Intestinales::Neoplasias Colorrectales [ENFERMEDADES] ,Research Article ,medicine.medical_specialty ,Population ,Context (language use) ,diagnóstico::diagnóstico precoz::detección precoz del cáncer [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,lcsh:RC254-282 ,Chronic disease ,Colorectal neoplasm ,03 medical and health sciences ,Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms [DISEASES] ,Genetics ,medicine ,Humans ,Health Services Administration::Patient Care Management::Comprehensive Health Care::Primary Health Care [HEALTH CARE] ,education ,Mass screening ,Preventive healthcare ,Aged ,business.industry ,medicine.disease ,Salut pública ,Diagnosis::Early Diagnosis::Early Detection of Cancer [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT] ,Cross-Sectional Studies ,Socioeconomic Factors ,Spain ,Physical therapy ,administración de los servicios de salud::gestión de la atención al paciente::atención integral de salud::atención primaria de la salud [ATENCIÓN DE SALUD] ,business ,Body mass index ,Demography - Abstract
Colorectal neoplasm; Early detection of cancer; Mass screening Neoplàsia colorrectal; Detecció precoç del càncer; Cribratge massiu Neoplasia colorrectal; Detección temprana de cáncer; Cribaje masivo BACKGROUND There is controversy regarding how comorbidity impacts on colorectal cancer screening, especially in the context of organised programmes. The aim of this study is to assess the effect of comorbidities on participation in the Barcelona population-based colorectal cancer screening programme (BCCSP). METHODS Cross-sectional study carried out in ten primary care centres involved in the BCCSP. Individuals aged 50 to 69, at average risk of colorectal cancer, who were invited to participate in the first round of the faecal immunochemical test-based BCCSP were included (2011-2012). The main variable was participation in the BCCSP. Comorbidity was assessed by clinical risk group status. Other adjusting variables were age, sex, socioeconomic deprivation, visits to primary care, smoking, alcohol consumption and body mass index. Logistic regression models were used to test the association between participation in the programme and potential explanatory variables. The results were given as incidence rate ratios (IRR) and their 95% confidence intervals (CI). RESULTS Of the 36,208 individuals included, 17,404 (48%) participated in the BCCSP. Participation was statistically significantly higher in women, individuals aged 60 to 64, patients with intermediate socioeconomic deprivation, and patients with more medical visits. There was a higher rate of current smoking, high-risk alcohol intake, obesity and individuals in the highest comorbidity categories in the non-participation group. In the adjusted analysis, only individuals with multiple minor chronic diseases were more likely to participate in the BCCSP (IRR 1.14; 95% CI [1.06 to 1.22]; p < 0.001). In contrast, having three or more dominant chronic diseases was associated with lower participation in the screening programme (IRR 0.76; 95% CI [0.65 to 0.89]; p = 0.001). CONCLUSIONS Having three or more dominant chronic diseases, was associated with lower participation in a faecal immunochemical test-based colorectal cancer screening programme, whereas individuals with multiple minor chronic diseases were more likely to participate. Further research is needed to explore comorbidity as a cause of non-participation in colorectal cancer screening programmes and which individuals could benefit most from colorectal cancer screening.
- Published
- 2017
41. What would primary care practitioners do differently after a delayed cancer diagnosis? Learning lessons from their experiences.
- Author
-
Koskela TH, Esteva M, Mangione M, Contreras Martos S, Hajdarevic S, Högberg C, Marzo-Castillejo M, Sawicka-Powierza J, Siliņa V, Harris M, and Petek D
- Subjects
- Humans, Communication, Health Personnel, Primary Health Care, Physicians, Primary Care, Neoplasms diagnosis
- Abstract
Objective: Diagnosis of cancer is challenging in primary care due to the low incidence of cancer cases in primary care practice. A prolonged diagnostic interval may be due to doctor, patient or system factors, or may be due to the characteristics of the cancer itself. The objective of this study was to learn from Primary Care Physicians' (PCP) experiences of incidents when they had failed to think of, or act on, a cancer diagnosis., Design: A qualitative, online survey eliciting PCP narratives. Thematic analysis was used to analyse the data., Setting and Subjects: A primary care study, with narratives from 159 PCPs in 23 European countries., Main Outcome Measures: PCPs' narratives on the question 'If you saw this patient with cancer presenting in the same way today, what would you do differently?, Results: The main themes identified were: thinking broadly; improvement in communication and clinical management; use of other available resources and 'I wouldn't do anything differently'., Conclusion (implications): To achieve more timely cancer diagnosis, PCPs need to provide a long-term, holistic and active approach with effective communication, and to ensure shared decision-making, follow-up and continuing re-assessment of the patients' clinical conditions.
- Published
- 2024
- Full Text
- View/download PDF
42. Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human.
- Author
-
García-Sancha N, Corchado-Cobos R, Blanco-Gómez A, Cunillera Puértolas O, Marzo-Castillejo M, Castillo-Lluva S, Alonso-López D, De Las Rivas J, Pozo J, Orfao A, Valero-Juan L, Patino-Alonso C, Perera D, Venkitaraman AR, Mao JH, Chang H, Mendiburu-Eliçabe M, González-García P, Caleiras E, Peset I, Cenador MBG, García-Criado FJ, and Pérez-Losada J
- Abstract
Post-pregnancy breast cancer often carries a poor prognosis, posing a major clinical challenge. The increasing trend of later-life pregnancies exacerbates this risk, highlighting the need for effective chemoprevention strategies. Current options, limited to selective estrogen receptor modulators, aromatase inhibitors, or surgical procedures, offer limited efficacy and considerable side effects. Here, we report that cabergoline, a dopaminergic agonist, reduces the risk of breast cancer post-pregnancy in a Brca1/P53 -deficient mouse model, with implications for human breast cancer prevention. We show that a single dose of cabergoline administered post-pregnancy significantly delayed the onset and reduced the incidence of breast cancer in Brca1/P53 -deficient mice. Histological analysis revealed a notable acceleration in post-lactational involution over the short term, characterized by increased apoptosis and altered gene expression related to ion transport. Over the long term, histological changes in the mammary gland included a reduction in the ductal component, decreased epithelial proliferation, and a lower presence of recombinant Brca1/P53 target cells, which are precursors of tumors. These changes serve as indicators of reduced breast cancer susceptibility. Additionally, RNA sequencing identified gene expression alterations associated with decreased proliferation and mammary gland branching. Our findings highlight a mechanism wherein cabergoline enhances the protective effect of pregnancy against breast cancer by potentiating postlactational involution. Notably, a retrospective cohort study in women demonstrated a markedly lower incidence of post-pregnancy breast cancer in those treated with cabergoline compared to a control group. Our work underscores the importance of enhancing postlactational involution as a strategy for breast cancer prevention, and identifies cabergoline as a promising, low-risk option in breast cancer chemoprevention. This strategy has the potential to revolutionize breast cancer prevention approaches, particularly for women at increased risk due to genetic factors or delayed childbirth, and has wider implications beyond hereditary breast cancer cases., Competing Interests: Competing interests The authors declare that they have no competing interests.
- Published
- 2024
- Full Text
- View/download PDF
43. Exploring why European primary care physicians sometimes do not think of, or act on, a possible cancer diagnosis. A qualitative study.
- Author
-
Hajdarevic S, Högberg C, Marzo-Castillejo M, Siliņa V, Sawicka-Powierza J, Esteva M, Koskela T, Petek D, Contreras-Martos S, Mangione M, Ožvačić Adžić Z, Asenova R, Gašparović Babić S, Brekke M, Buczkowski K, Buono N, Çifçili SS, Dinant GJ, Doorn B, Hoffman RD, Kuodza G, Murchie P, Pilv L, Puia A, Rapalavicius A, Smyrnakis E, Weltermann B, and Harris M
- Abstract
Background: While primary care physicians (PCPs) play a key role in cancer detection, they can find cancer diagnosis challenging, and some patients have considerable delays between presentation and onward referral., Aim: To explore European PCPs' experiences and views on cases where they considered that they had been slow to think of, or act on, a possible cancer diagnosis., Design & Setting: A multicentre European qualitative study, based on an online survey with open-ended questions, asking PCPs for their narratives about cases when they had missed a diagnosis of cancer., Method: Using maximum variation sampling, PCPs in 23 European countries were asked to describe what happened in a case where they were slow to think of a cancer diagnosis, and for their views on why it happened. Thematic analysis was used to analyse the data., Results: A total of 158 PCPs completed the questionnaire. The main themes were as follows: patients' descriptions did not suggest cancer; distracting factors reduced PCPs' cancer suspicions; patients' hesitancy delayed the diagnosis; system factors not facilitating timely diagnosis; PCPs felt that they had acted wrongly; and problems with communicating adequately., Conclusion: The study identified six overarching themes that need to be addressed. Doing so should reduce morbidity and mortality in the small proportion of patients who have a significant, avoidable delay in their cancer diagnosis. The 'Swiss cheese' model of accident causation showed how the themes related to each other., (Copyright © 2023, The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
44. [Health professionals' perspective about women's experiences during the diagnostic process of ovarian cancer in Catalonia: Qualitative study].
- Author
-
Marzo-Castillejo M, Vela-Vallespín C, Mascort Roca J, Guiriguet Capdevila C, Codern-Bové N, and Borras JM
- Subjects
- Humans, Female, Spain, Qualitative Research, Focus Groups, Health Personnel, Ovarian Neoplasms diagnosis
- Abstract
Objective: To identify missed opportunities in the diagnosis of ovarian cancer (OC) in the public health system of Catalonia, through the analysis of the perceptions of health professionals on the stories's experiences of OC patients., Design: Qualitative exploratory-descriptive study, with two focus groups., Setting: Primary Care, November 2017., Participants: Thirty-four professionals based on theoretical sampling: 21 family doctors, 8 professionals from sexual and reproductive health centres and 5 hospital gynaecologists., Methods: Participants discussed the different diagnostic pathways for women with OC through the presentation of flowcharts which were developed with three storie's and experiences of OC patients., Results: Three themes with various sub-themes were identified as follow: a)lack of cancer diagnostic suspicion (lack of knowledge of symptoms of OC, anamnesis and physical examination overlooked, fragmentation of patient's care and bias and prejudice); b)difficulties in activating the diagnostic process (limited access to tests, unequal accessibility to gynaecology and lack of follow-up); and c)absence of fast-track referral system., Conclusions: The results offer insight into the difficulties of early diagnosis of OC in our setting. We believe that their identification will allow the development of strategies to improve diagnostic accuracy and quality of care for women with OC in our setting., (Copyright © 2023 The Author(s). Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
45. Cancer diagnosis in primary care after second pandemic year in Catalonia: a time-series analysis of primary care electronic health records covering about 5 million people.
- Author
-
Mora N, Guiriguet C, Cantenys R, Méndez-Boo L, Marzo-Castillejo M, Benítez M, Fina F, Fàbregas M, Hermosilla E, Mercadé A, Medina M, and Coma E
- Subjects
- Male, Humans, Electronic Health Records, Pandemics, Spain epidemiology, Communicable Disease Control, Primary Health Care, COVID-19 Testing, COVID-19 diagnosis, COVID-19 epidemiology, Neoplasms diagnosis, Neoplasms epidemiology
- Abstract
Background: During the COVID-19 pandemic, the incidence of chronic disease had drastically been reduced due to health care interruptions. The aim of this study is to analyse cancer diagnosis during the last 2 years of the COVID-19 pandemic., Methods: Time-series study of cancer diagnoses recorded in primary care settings, using data from the primary care electronic health records from January 2014 to December 2021. We obtained the expected monthly rate per 100,000 inhabitants using a time regression adjusted by trend and seasonality. We additionally compared rates of cancer diagnoses in 2019 with those of 2020 and 2021 using the t-test. We performed the analysis globally, by sex and by type of cancer., Results: In 2020, the rate of cancer diagnoses had reduced by -21% compared to 2019 (P < 0.05). Greater reductions were observed during the lockdown in early 2020 (>40%) and with some types of cancers, especially prostate and skin cancers (-29.6% and -26.9%, respectively, P < 0.05). Lung cancers presented statistically non-significant reductions in both years. Cancer diagnosis returned to expected around March 2021, and the rate in 2021 was similar to that of 2019 (overall difference of 0.21%, P = 0.967). However, an 11% reduction was still found when comparing the pandemic months of 2020-2021 with pre-pandemic months., Conclusions: Although primary care cancer diagnoses in 2021 have returned to pre-pandemic levels, missing diagnoses during the last 2 years have not been fully recovered., (© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
46. Women's experiences along the ovarian cancer diagnostic pathway in Catalonia: A qualitative study.
- Author
-
Vela-Vallespín C, Medina-Perucha L, Jacques-Aviñó C, Codern-Bové N, Harris M, Borras JM, and Marzo-Castillejo M
- Subjects
- Female, Humans, Spain, Qualitative Research, Delivery of Health Care, Ovarian Neoplasms diagnosis
- Abstract
Background: Early detection of symptoms and prompt diagnosis of ovarian cancer are considered important avenues for improving patient experiences and outcomes., Methods: This qualitative study used a phenomenological approach to perform patient interviews, collecting individual accounts of the prediagnostic phase in women diagnosed and treated for ovarian cancer in 2016-2017. Purposive sampling was used to obtain a diverse sample of 24 participants, while thematic content analysis was used to extract themes and subthemes from interview data., Results: Three themes and nine subthemes were identified. The first theme was women's delay in recognizing symptoms and seeking care, with subthemes on the lack of knowledge about early signs of ovarian cancer, gender-related barriers and false reassurance from negative test results. A second theme was missed opportunities during healthcare encounters, due to misattribution of women's symptoms by their physicians, underestimation of symptom severity and need for mediation and inadequate tests and/or false negative results. Finally, interviews highlighted the use of resources and alternative healthcare pathways, including complementary/alternative medicines, access to private health care and women's capacity for action and decision-making (agency) about their health., Conclusion: Delayed diagnosis of ovarian cancer is rooted in both individual factors (lack of health literacy, reluctance to seek care) and systemic issues (missed opportunities in healthcare encounters, access to timely specialist care). Further research is needed to investigate the extent to which traditional gender roles and socioeconomic inequalities condition women's ability to manage their own health and to interact with health professionals and the health system., Patient and Public Contribution: In addition to the patient participation during the interviews, one author was a representative of a patient association., (© 2022 The Authors. Health Expectations published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
47. [PAPPS Expert Groups. Cancer prevention recommendations: Update 2022].
- Author
-
Marzo-Castillejo M, Bartolomé-Moreno C, Bellas-Beceiro B, Melús-Palazón E, and Vela-Vallespín C
- Subjects
- Humans, Risk Factors, Life Style, Diet, Mass Screening, Neoplasms diagnosis, Neoplasms epidemiology, Neoplasms prevention & control
- Abstract
Cancer is a major cause of morbidity and mortality. Tobacco use, unhealthy diet, and physical inactivity are some of the lifestyle risk factors that have led to an increase in cancer. This article updates the evidence and includes recommendations for prevention strategies for each of the cancers with the highest incidence. These are based on the reduction of risk factors (primary prevention) and early diagnosis of cancer through screening and early detection of signs and symptoms, in medium-risk and high-risk populations. This update of the 2022 PAPPS has taken into account the vision of the National Health System Cancer Strategy, an update approved by the Interterritorial Council of the National Health System on January 2021 and the European Strategy (Europe's Beating Cancer Plan) presented on 4 February 2021., (Copyright © 2022 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
48. Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort study.
- Author
-
Vela-Vallespín C, Manchon-Walsh P, Aliste L, Borras JM, and Marzo-Castillejo M
- Subjects
- Carcinoma, Ovarian Epithelial, Child, Preschool, Cohort Studies, Female, Humans, Primary Health Care, Retrospective Studies, Spain epidemiology, Emergency Medical Services, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms drug therapy, Ovarian Neoplasms therapy
- Abstract
Objective: To assess the impact of prehospital factors (diagnostic pathways, first presentation to healthcare services, intervals, participation in primary care) on 1-year and 5-year survival in people with epithelial ovarian cancer (EOC)., Design: Retrospective quasi-population-based cohort study., Setting: Catalan Integrated Public Healthcare System., Participants: People with EOC who underwent surgery with a curative intent in public Catalan hospitals between 1 January 2013 and 31 December 2014., Outcome Measures: Data from primary and secondary care clinical histories and care processes in the 18 months leading up to confirmation (signs and symptoms at presentation, diagnosis pathways, referrals, diagnosis interval) of the EOC diagnosis (stage, histology type, treatment). Diagnostic process intervals were based on the Aarhus statement. 1-year and 5-year survival analysis was undertaken., Results: Of the 513 patients included in the cohort, 67.2% initially consulted their family physician, while 36.4% were diagnosed through emergency services. In the Cox models, survival was influenced by advanced stage at 1 year (HR 3.84, 95% CI 1.23 to 12.02) and 5 years (HR 5.36, 95% CI 3.07 to 9.36), as was the type of treatment received, although this association was attenuated over follow-up. Age became significant at 5 years of follow-up. After adjusting for age, adjusted morbidity groups, stage at diagnosis and treatment, 5-year survival was better in patients presenting with gynaecological bleeding (HR 0.35, 95% CI 0.16 to 0.79). Survival was not associated with a starting point involving primary care (HR 1.39, 95% CI 0.93 to 2.09), diagnostic pathways involving referral to elective gynaecological care from non-general practitioners (HR 0.80, 95% CI 0.51 to 1.26), or self-presentation to emergency services (HR 0.82, 95% CI 0.52 to 1.31)., Conclusions: Survival in EOC is not associated with diagnostic pathways or prehospital healthcare, but it is influenced by stage at diagnosis, administration of primary cytoreduction plus chemotherapy and patient age., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
49. Evaluating the controlled reopening of nightlife during the COVID-19 pandemic: a matched cohort study in Sitges, Spain, in May 2021 (Reobrim Sitges).
- Author
-
Cunillera Puértolas O, Contreras-Martos S, Marzo-Castillejo M, López Gallegos D, Acedo Anta M, Almeda Ortega J, Colom J, Basora J, and Salvador-Gonzalez B
- Subjects
- Adult, Cohort Studies, Female, Humans, Pandemics, SARS-CoV-2, Spain epidemiology, COVID-19 epidemiology, COVID-19 prevention & control
- Abstract
Objectives: To assess the impact of relaxing the state of alarm restrictions on SARS-CoV-2 infections at 14 days among people attending reopened nightclub venues., Design: Matched cohort study with a paired control group (1:5 ratio)., Setting: Five small nightclubs with indoor areas and outdoor terraces, in a nightlife-restricted area in Sitges, Spain, on 20 May 2021. Wearing masks was mandatory, drinking was allowed and social distance was not required., Participants: Volunteers were selected through a convenience sampling. To attend the event, participants were required to be older than 17 years, with a negative rapid antigen diagnostic test (Ag-RDT) on the same afternoon, without a positive reverse-transcription PCR (RT-PCR) or Ag-RDT and/or symptoms associated with COVID-19 in the previous 7 days, to not having knowingly been in close contact with someone infected in the previous 10 days and to not have knowingly had close contact with someone with a suspicion of COVID-19 in the previous 48 hours. A control group was paired by exact age, gender, residence municipality, socioeconomic index, previous SARS-CoV-2-confirmed infection and vaccination status, in a 1:5 ratio, from the primary care electronic health records., Primary Outcome: Evidence of infection at electronic health records by SARS-CoV-2 at 14-day follow-up., Results: Among the 391 participants (median age 37 years; 44% (n=173) women), no positive SARS-CoV-2 cases were detected at 14 days, resulting in a cumulative incidence estimation of 0 (95% CI 0 to 943) per 100 000 inhabitants. In the control group, two cases with RT-PCR test were identified, resulting in a cumulative incidence of 102.30 (12.4 to 369) per 100 000 inhabitants., Conclusions: Nightlife attendance under controlled conditions and with a requirement for a negative Ag-RDT was not associated with increased transmissibility of SARS-CoV-2 in a pandemic context of low infection rates. In such circumstances, secure opening of the nightlife sector was possible, under reduced capacity and controlled access by Ag-RDT, and environments where compliance with sanitary measures are maintainable., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
50. [The impact of COVID-19 on cancer diagnosis delay: possible consequences].
- Author
-
Marzo-Castillejo M, Guiriguet Capdevila C, and Coma Redon E
- Subjects
- Delayed Diagnosis, Humans, SARS-CoV-2, Time-to-Treatment, COVID-19, Neoplasms diagnosis
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.